We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+10.39%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$716M
AUM Growth
+$28.2M
Cap. Flow
-$7.46M
Cap. Flow %
-1.04%
Top 10 Hldgs %
16.05%
Holding
426
New
40
Increased
110
Reduced
102
Closed
56

Top Buys

Rank Stock Value
1
PRIM icon
Primoris Services
PRIM
+$6.62M
2
XYL icon
Xylem
XYL
+$5.51M
3
GMED icon
Globus Medical
GMED
+$5.42M
4
NEWR
New Relic, Inc.
NEWR
+$4.87M
5
BOX icon
Box
BOX
+$4.76M

Sector Composition

Rank Sector Weight
1 Technology 28.28%
2 Industrials 23.37%
3 Healthcare 15.83%
4 Materials 7.53%
5 Consumer Discretionary 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
226
Bristol-Myers Squibb
BMY
$132B
$835K 0.12%
13,063
BA icon
227
Boeing
BA
$181B
$830K 0.12%
3,930
+22
+0.6% +$4.57K
ORN icon
228
Orion Group Holdings
ORN
$393M
$823K 0.11%
292,953
+7,418
+3% +$18.9K
CBOE icon
229
Cboe Global Markets
CBOE
$30.4B
$820K 0.11%
5,939
-398
-6% -$54.3K
TACT icon
230
Transact Technologies
TACT
$53M
$816K 0.11%
91,125
+2,295
+3% +$16.2K
CSCO icon
231
Cisco
CSCO
$445B
$809K 0.11%
+15,639
New +$769K
BWEN icon
232
Broadwind
BWEN
$126M
$808K 0.11%
211,456
+4,860
+2% +$20.3K
CRWD icon
233
CrowdStrike
CRWD
$227B
$785K 0.11%
+21,388
New +$745K
KO icon
234
Coca-Cola
KO
$377B
$765K 0.11%
12,701
VZ icon
235
Verizon
VZ
$198B
$755K 0.11%
20,289
-1,564
-7% -$57.9K
CSBR icon
236
Champions Oncology
CSBR
$67.8M
$710K 0.1%
111,340
+3,685
+3% +$19K
AMD icon
237
Advanced Micro Devices
AMD
$802B
$709K 0.1%
+6,225
New +$647K
GEOS icon
238
Geospace Technologies
GEOS
$65.5M
$707K 0.1%
90,993
+2,456
+3% +$19.5K
STRR
239
Star Equity Holdings
STRR
$37.8M
$693K 0.1%
32,174
+806
+3% +$17.1K
GNSS icon
240
Genasys
GNSS
$77M
$687K 0.1%
264,337
+6,136
+2% +$16.9K
ACLS icon
241
Axcelis
ACLS
$4.43B
$683K 0.1%
3,725
SPY icon
242
State Street SPDR S&P 500 ETF Trust
SPY
$813B
$672K 0.09%
1,516
-753
-33% -$316K
CHRN
243
ChronoScale Holdings
CHRN
$2.94B
$650K 0.09%
30,307
+703
+2% +$15.6K
APT icon
244
Alpha Pro Tech
APT
$55.3M
$645K 0.09%
162,079
+4,351
+3% +$17.1K
PERI icon
245
Perion Network
PERI
$378M
$621K 0.09%
20,249
-7,432
-27% -$255K
SANW
246
DELISTED
S&W Seed Co
SANW
$604K 0.08%
26,068
+508
+2% +$12.1K
VTSI icon
247
VirTra
VTSI
$37.2M
$596K 0.08%
78,326
+1,954
+3% +$13K
MDWD icon
248
MediWound
MDWD
$175M
$596K 0.08%
55,907
+1,295
+2% +$14K
FNV icon
249
Franco-Nevada
FNV
$44.8B
$570K 0.08%
3,995
-166
-4% -$24.9K
ONDS icon
250
Ondas Inc
ONDS
$5.15B
$569K 0.08%
+660,934
New +$629K

Similar funds

Essex Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, Essex Investment Management held 426 positions worth $716M, up 4.1% from $688M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Essex Investment Management's Q2 2023 filing shows 40 new, 110 increased, 102 reduced and 56 closed positions. Its largest new stake was Primoris Services: 247,370 shares worth $7.54M. The largest sale was Castle Biosciences, an estimated $10.9M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Industrials and Healthcare.

  • Essex Investment Management's largest Q2 2023 buy was Primoris Services: 247,370 shares worth $7.54M.
  • Essex Investment Management added most to Xylem in Q2 2023, an estimated $5.51M increase.
  • Essex Investment Management's biggest Q2 2023 reduction was Energy Recovery, cutting an estimated $4.08M.
  • Essex Investment Management fully exited Castle Biosciences in Q2 2023, selling an estimated $10.9M.
  • Essex Investment Management's ten largest holdings make up 16% of its $716M portfolio in Q2 2023.
  • Essex Investment Management opened 40 new positions and closed 56 in Q2 2023.
  • Essex Investment Management's portfolio value rose 4.1% quarter-over-quarter to $716M.

Based on Essex Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.